KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Opko Health (OPK) Depreciation & Amortization (CF) (2016 - 2025)

Historic Depreciation & Amortization (CF) for Opko Health (OPK) over the last 16 years, with Q3 2025 value amounting to $22.7 million.

  • Opko Health's Depreciation & Amortization (CF) fell 589.33% to $22.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $93.3 million, marking a year-over-year decrease of 681.98%. This contributed to the annual value of $98.2 million for FY2024, which is 676.28% down from last year.
  • Latest data reveals that Opko Health reported Depreciation & Amortization (CF) of $22.7 million as of Q3 2025, which was down 589.33% from $23.0 million recorded in Q2 2025.
  • In the past 5 years, Opko Health's Depreciation & Amortization (CF) ranged from a high of $28.0 million in Q2 2022 and a low of $19.0 million during Q3 2021
  • Moreover, its 5-year median value for Depreciation & Amortization (CF) was $24.2 million (2024), whereas its average is $24.3 million.
  • In the last 5 years, Opko Health's Depreciation & Amortization (CF) plummeted by 985.45% in 2021 and then soared by 4762.96% in 2022.
  • Opko Health's Depreciation & Amortization (CF) (Quarter) stood at $19.2 million in 2021, then surged by 37.88% to $26.5 million in 2022, then dropped by 1.81% to $26.0 million in 2023, then dropped by 7.48% to $24.0 million in 2024, then dropped by 5.41% to $22.7 million in 2025.
  • Its last three reported values are $22.7 million in Q3 2025, $23.0 million for Q2 2025, and $23.5 million during Q1 2025.